Why investors are taking another look at kidney disease
October 22, 2026 | 1 min read | In this episode of Denatured, you’ll hear from Bruce Culleton, CEO at ProKidney and…
October 22, 2026 | 1 min read | In this episode of Denatured, you’ll hear from Bruce Culleton, CEO at ProKidney and…